ALL KEYWORDSER-Positive Breast CancerRelated SpecialistsShowing 3 of 40Neal FischbachMDMichael DiGiovannaMD, PhDKathleen FennMDMore Related SpecialistsRelated Clinical TrialsShowing 2 of 3An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast CancerBreast CancerA pilot study to evaluate biomarkers and safety of dapagliflozin concomitant with neoadjuvant therapy for patient with HER2-negative early-stage breast cancer and hyperinsulinemiaBreast CancerMore Related Clinical Trials
